Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokuni Taguchi

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Diseases of the Colon and Rectum|March 11, 2003
Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colonYoshifumi Higashidani, Satoru Tamura, Tomoko Morita, et al.
International Journal of Hematology|June 29, 2004
Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemiaKazunori Ohnishi, Akio Ino, Yuji Kishimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphomaMasanori Daibata, Yuiko Nemoto, Kentaro Bandobashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancerSigal Gery, Naoki Komatsu, Norihiko Kawamata, et al.
Molecular Cancer Therapeutics|June 2, 2007
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemiaTakayuki Ikezoe, Jing Yang, Chie Nishioka, et al.
Blood|May 15, 2007
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivoJing Yang, Takayuki Ikezoe, Chie Nishioka, et al.
Oncology Reports|June 18, 2004
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemiaChise Matsushita, Yang Yang, Seisho Takeuchi, et al.
Leukemia Research|July 26, 2005
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemiaYang Yang, Seisho Takeuchi, Wolf K Hofmann, et al.
International Journal of Hematology|July 5, 2003
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphomaKensei Tobinai, Naokuni Uike, Yoshio Saburi, et al.
Japanese Journal of Cancer Research : Gann|April 30, 2003
Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysisYasuyuki Kaneta, Yoshitoyo Kagami, Toyomasa Katagiri, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Diseases of the Colon and Rectum|March 11, 2003
Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colonYoshifumi Higashidani, Satoru Tamura, Tomoko Morita, et al.
International Journal of Hematology|June 29, 2004
Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemiaKazunori Ohnishi, Akio Ino, Yuji Kishimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphomaMasanori Daibata, Yuiko Nemoto, Kentaro Bandobashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancerSigal Gery, Naoki Komatsu, Norihiko Kawamata, et al.
Molecular Cancer Therapeutics|June 2, 2007
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemiaTakayuki Ikezoe, Jing Yang, Chie Nishioka, et al.
Blood|May 15, 2007
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivoJing Yang, Takayuki Ikezoe, Chie Nishioka, et al.
Oncology Reports|June 18, 2004
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemiaChise Matsushita, Yang Yang, Seisho Takeuchi, et al.
Leukemia Research|July 26, 2005
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemiaYang Yang, Seisho Takeuchi, Wolf K Hofmann, et al.
International Journal of Hematology|July 5, 2003
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphomaKensei Tobinai, Naokuni Uike, Yoshio Saburi, et al.
Japanese Journal of Cancer Research : Gann|April 30, 2003
Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysisYasuyuki Kaneta, Yoshitoyo Kagami, Toyomasa Katagiri, et al.
Pageof 8